News & Events

• October 25, 2018
  

  FNIH Biomarkers Consortium and Critical Path Institute Achieve the First Ever Qualification of a Clinical Safety Biomarker by the U.S. Food and Drug Administration

  Major Milestone will Improve Detection of Drug-Induced Acute Kidney Injury in Clinical Trials.     October 25, 2018 — The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium (BC) and the Critical Path Institute (C-Path) Predictive Safety Testing Consortium (PSTC) have received the first ever qualification of a clinical safety biomarker awarded by...
• October 24, 2018 - October 27, 2018
  

  11th Clinical Trials on Alzheimer’s Disease (CTAD)

  The Clinical Trials on Alzheimer’s Disease (CTAD) conference is an important annual scientific meeting where latest developments and research results from clinical Alzheimer disease trials are shared and discussed. Researchers and participants from pharma, academia, patent-advocacy organizations and other groups are coming together in Barcelona, Spain, between October 24th and 27th. Each year, on behalf...
• October 7, 2018 - October 10, 2018
  

  9th Annual Conference of Pharmacometrics (ACoP9)

  The ninth Annual Conference of Pharmacometrics (ACoP9) is the annual scientific meeting of the International Society of Pharmacometrics. More than 650 researchers and participants from pharma, academia, and non-government organizations attended ACoP9 in San Diego between October 6th and 11th to exchange the latest research and application of quantitative methods to pharmaceutics. Members of the...
• September 27, 2018 - September 28, 2018
  

  Workshop on Evidence-Based Treatment Decisions in Transplantation Informs PRO and Patient-Focused Drug Development

    The U.S. Food and Drug Administration (FDA) held a public workshop on September 27-28, 2018 at its White Oak Campus in Silver Spring, MD. titled “Evidence-Based Treatment Decisions in Transplantation: The Right Dose & Regimen for the Right Patient/Individualized Treatment.” The workshop was planned and presented in collaboration with the Transplant Therapeutics Consortium (TTC),...
• September 25, 2018
  

  UA Colleges of Law and Pharmacy, Critical Path Institute, Launch Graduate Certificate Program in Regulatory Science

  Designed for graduate students and working professionals, the certificate program provides specialized training in navigating the path from research to bringing medical products to market.   TUCSON, Ariz., September 25, 2018 — The University of Arizona and the Critical Path Institute have launched a new online graduate certificate program designed to equip students and working...